NCT06969625 Shoulder Anterior Capsular Block for Postoperative Analgesia in Arthroscopic Rotator Cuff Repair Surgery
| NCT ID | NCT06969625 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Zagazig University |
| Condition | Arthroscopic Rotator Cuff Repair |
| Study Type | INTERVENTIONAL |
| Enrollment | 60 participants |
| Start Date | 2025-06-01 |
| Primary Completion | 2026-01-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 60 participants in total. It began in 2025-06-01 with a primary completion date of 2026-01-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Shoulder pain is frequently encountered in the medical field. Rotator cuff tears are the most common cause. Shoulder pain affects quality of life and delay rehabilitation programs. Effective control of post operative pain is a cornerstone in the success of these surgeries. Regional anaesthesia is often favoured for shoulder surgery as it could effectively provide anaesthesia and postoperative analgesia. Additionally, the upper limb has multiple nerve targets that can be blocked. Ultrasound combined SSNB-ANB were described as an alternative to interscalene nerve block for shoulder surgeries equipotent pain relief and patient satisfaction as well as fewer complications due to the location of injection. Ultrasound guided SHAC block is a motor sparing block which targets all nerves supplying shoulder consistently at two sites. It was validated in chronic shoulder pain patients. However, there is no sufficient evidence for this block in postoperative pain after shoulder surgery.
Eligibility Criteria
Inclusion Criteria: * Patients acceptance * Age: 21-60 years * Sex: both sexes (males or females). * Physical status: ASA 1\& II. * Body mass index (BMI) ≤ 30 kg/m2 * Type of operation: arthroscopic rotator cuff repair surgery. * Duration of surgery: within 2 hours. Exclusion Criteria: * Patient with any contraindications of regional blocks (as coagulopathy or local infection at injection site) * Patients with known history of allergy to the study drugs. * patients with neuropathy involving the limb undergoing surgery * Advanced hepatic, renal, cardiovascular, and neurologic diseases. * history of previous shoulder operation or fracture. * conversion to open surgery from arthroscopy. * pregnant females * patients with chronic opioid use
Contact & Investigator
Shereen E. Abd Ellatif, MD
STUDY DIRECTOR
Anaesthesia, Intensive Care, and Pain Management Department. Faculty of Medicine, Zagazig University
Frequently Asked Questions
Who can join the NCT06969625 clinical trial?
This trial is open to participants of all sexes, aged 21 Years or older, up to 65 Years, studying Arthroscopic Rotator Cuff Repair. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06969625 currently recruiting?
Yes, NCT06969625 is actively recruiting participants. Contact the research team at sherifmowafy2012@gmail.com for enrollment information.
Where is the NCT06969625 trial being conducted?
This trial is being conducted at Zagazig, Egypt.
Who is sponsoring the NCT06969625 clinical trial?
NCT06969625 is sponsored by Zagazig University. The principal investigator is Shereen E. Abd Ellatif, MD at Anaesthesia, Intensive Care, and Pain Management Department. Faculty of Medicine, Zagazig University. The trial plans to enroll 60 participants.